A clinical study of ATP087 cream and ra76 cream on atopic dermatitis.
- Conditions
- Atopic dermatitis
- Registration Number
- JPRN-UMIN000031190
- Lead Sponsor
- Exam CO.,LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 23
Not provided
1) Patients with severe skin disorders on test site (both arms) and deemed inappropriate to participate in this study by the principal investigator or sub-investigators. 2) Patients with any complications which affect the results of this study. 3) Patients who might use any external use medicines, anti-allergy drugs, or immunosuppressants. 4) Patients with a past history of allergy with test drug components. 5) Patients with hemorrhagic disease. 6) Patients with risk of serious disease in an injury. 7) Patients with menopausal trouble or on menopausal hormone therapy 8) Pregnant or lactating patients. Patients with suspicion of pregnancy. 9) Patients deemed inappropriate to participate in this study by the principal investigator or sub-investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Transition of severity classification (simple method) of atopic dermatitis developed by the advisory committee of atopic dermatitis severity classification of Japanese Dermatological Association at test site (both arms).
- Secondary Outcome Measures
Name Time Method 1) Transepidermal water loss, water content of the stratum corneum, erythema and pigmentation, and skin surface topography at test site (both arms), etc. 2) Questionnaires for QOL assessment in atopic dermatitis.